You are here

  • Home
  • Archive
  • Volume 11, Issue 6
  • Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance

Article info

Article menu
Basic tumor immunology
Original research
Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance

Authors

  • Xuan Zou Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Xuan Lin Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • He Cheng Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Yusheng Chen Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Ruijie Wang Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Mingjian Ma Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Yu Liu Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Zhengjie Dai Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Yesboli Tasiheng Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Yu Yan Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Qinqin Hou Department of Pathology Oncology, Fudan University Shanghai Cancer Center, Shanghai, China PubMed articlesGoogle scholar articles
  • Fei Ding Department of Pathology Oncology, Fudan University Shanghai Cancer Center, Shanghai, China PubMed articlesGoogle scholar articles
  • Huan Chen Department of Pathology Oncology, Fudan University Shanghai Cancer Center, Shanghai, China PubMed articlesGoogle scholar articles
  • Xianjun Yu Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Xu Wang Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of ChinaShanghai Key Laboratory of Radiation Oncology, Cancer Research Institute, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Chen Liu Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Shanghai, People's Republic of ChinaShanghai Pancreatic Cancer Institute, Shanghai, People's Republic of ChinaPancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles

Citation

Zou X, Lin X, Cheng H, et al
Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance
Journal for ImmunoTherapy of Cancer 2023;11:e006698. doi: 10.1136/jitc-2023-006698
Online issue publication 
June 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.